Efficacy and safety of canagliflozin compared with placebo and sitagliptin in patients with type 2 diabetes on background metformin monotherapy: a randomised trial

AIMS/HYPOTHESIS: The aim of this work was to evaluate the efficacy and safety of canagliflozin vs placebo and sitagliptin in patients with type 2 diabetes who were being treated with background metformin. METHODS: This randomised, double-blind, four-arm, parallel-group, Phase 3 study was conducted a...

Descripción completa

Detalles Bibliográficos
Autores principales: Lavalle-González, F. J., Januszewicz, A., Davidson, J., Tong, C., Qiu, R., Canovatchel, W., Meininger, G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2013
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3825495/
https://www.ncbi.nlm.nih.gov/pubmed/24026211
http://dx.doi.org/10.1007/s00125-013-3039-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3825495/
https://www.ncbi.nlm.nih.gov/pubmed/24026211
http://dx.doi.org/10.1007/s00125-013-3039-1

Ejemplares similares